生物医药系列产品
数据
资源
版本对比
免费注册
预约演示
免费注册
Transgenic Chickens Help UK's Oxford Biomedica Fly
2004-06-21
·
BioSpace
抗体
LONDON (Reuters) - A potential breakthrough in the production of protein-based drugs in the eggs of genetically modified chickens lifted shares in British biotech firm Oxford Biomedica eight percent on Monday.
Biomedica
said it and U.S. partner
Viragen
had managed to generate transgenic chicken lines with an efficiency of the order of 10 to 100-fold higher than any previously published method. Several biotech groups are working on new ways to produce antibodies and other complex protein drugs in milk, eggs or farm crops, as a cheap alternative to making them from cell cultures in stainless steel vats. MeSH Headings: Animals, Laboratory : Animals, Transgenic : Invertebrates : Organisms, Transgenic Copyright © 2002 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Reuters
and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
机构
Viragen, Inc.
Biomedica Medizinprodukte GmbH.
Reuters Ltd.
适应症
-
靶点
-
药物
-
标准版
¥
16800
元/账号/年
新药情报库 | 省钱又好用!
立即使用
来和芽仔聊天吧
热门报告
特应性皮炎深度解析:药物开发、专利分析与风险评估
智慧芽生物医药
2024年7月全球首批及特殊审评药物报告
智慧芽生物医药
GPRC5D靶点专利调研报告
智慧芽生物医药
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
开始免费试用
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。
试用数据服务